457 related articles for article (PubMed ID: 26846350)
1. Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT.
Choi H; Cheon GJ; Kim HJ; Choi SH; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
Hum Brain Mapp; 2016 May; 37(5):1710-21. PubMed ID: 26846350
[TBL] [Abstract][Full Text] [Related]
2. Correlations between dopamine transporter density measured by
Maekawa T; Sato N; Ota M; Sugiyama A; Sone D; Enokizono M; Kimura Y; Mukai Y; Murata M; Takano H; Imabayashi E; Matsuda H; Kunimatsu A; Abe O
Jpn J Radiol; 2017 Dec; 35(12):755-759. PubMed ID: 29063467
[TBL] [Abstract][Full Text] [Related]
3. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
6. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
7. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
Kübler D; Schroll H; Buchert R; Kühn AA
J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
[TBL] [Abstract][Full Text] [Related]
8. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease.
Eshuis SA; Maguire RP; Leenders KL; Jonkman S; Jager PL
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):200-9. PubMed ID: 16228235
[TBL] [Abstract][Full Text] [Related]
9. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
[TBL] [Abstract][Full Text] [Related]
10. 18F-FP-CIT PET imaging and SPM analysis of dopamine transporters in Parkinson's disease in various Hoehn & Yahr stages.
Wang J; Zuo CT; Jiang YP; Guan YH; Chen ZP; Xiang JD; Yang LQ; Ding ZT; Wu JJ; Su HL
J Neurol; 2007 Feb; 254(2):185-90. PubMed ID: 17334953
[TBL] [Abstract][Full Text] [Related]
11. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic and Serotonergic Degeneration and Cortical [
Orso B; Arnaldi D; Girtler N; Brugnolo A; Doglione E; Mattioli P; Biassoni E; Fancellu R; Massa F; Bauckneht M; Chiola S; Morbelli S; Nobili F; Pardini M
Mov Disord; 2021 Oct; 36(10):2293-2302. PubMed ID: 34021923
[TBL] [Abstract][Full Text] [Related]
13. Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images.
Kas A; Payoux P; Habert MO; Malek Z; Cointepas Y; El Fakhri G; Chaumet-Riffaud P; Itti E; Remy P
J Nucl Med; 2007 Sep; 48(9):1459-67. PubMed ID: 17704252
[TBL] [Abstract][Full Text] [Related]
14. Segmentation-based MR attenuation correction including bones also affects quantitation in brain studies: an initial result of 18F-FP-CIT PET/MR for patients with parkinsonism.
Choi H; Cheon GJ; Kim HJ; Choi SH; Lee JS; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
J Nucl Med; 2014 Oct; 55(10):1617-22. PubMed ID: 25134529
[TBL] [Abstract][Full Text] [Related]
15. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
Booij J; Speelman JD; Horstink MW; Wolters EC
Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
[TBL] [Abstract][Full Text] [Related]
16. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
Song IU; Chung YA; Oh JK; Chung SW
Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison of
Lee I; Kim JS; Park JY; Byun BH; Park SY; Choi JH; Moon H; Kim JY; Lee KC; Chi DY; Kim KM; Lim I; Kang JH; Ahn SH; Kim BI; Ha JH; Lim SM
Synapse; 2018 Jul; 72(7):e22032. PubMed ID: 29486515
[No Abstract] [Full Text] [Related]
18. Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease.
Tassan Mazzocco M; Serra M; Maspero M; Coliva A; Presotto L; Casu MA; Morelli M; Moresco RM; Belloli S; Pinna A
Exp Neurol; 2024 Apr; 374():114704. PubMed ID: 38281587
[TBL] [Abstract][Full Text] [Related]
19. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
Kim H; Oh M; Oh JS; Moon H; Chung SJ; Lee CS; Kim JS
Nucl Med Commun; 2019 Dec; 40(12):1216-1223. PubMed ID: 31584466
[TBL] [Abstract][Full Text] [Related]
20. Regional cortical hypoperfusion and atrophy correlate with striatal dopaminergic loss in Parkinson's disease: a study using arterial spin labeling MR perfusion.
Kitazaki Y; Ikawa M; Yamaguchi T; Enomoto S; Shirafuji N; Yamamura O; Tsujikawa T; Okazawa H; Kimura H; Nakamoto Y; Hamano T
Neuroradiology; 2023 Mar; 65(3):569-577. PubMed ID: 36376524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
